CRISPR-Cas9 Engineered Extracellular Vesicles for the Treatment of Dominant Progressive Hearing Loss.
Pan X, Huang P, Ali SS, Renslo B, Hutchinson TE, Erwin N, Greenberg Z, Ding Z, Li Y, Warnecke A, Fernandez NE, Staecker H, He M.
Pan X, et al. Among authors: hutchinson te.
bioRxiv [Preprint]. 2023 Dec 15:2023.09.14.557853. doi: 10.1101/2023.09.14.557853.
bioRxiv. 2023.
PMID: 38168224
Free PMC article.
Preprint.